VANSEN PHARMA INC. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
VANSEN PHARMA INC. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of -$0.03 per share for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-12-04.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2013-12-04
- VANSEN PHARMA INC. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2013-09-30 was -$0.03.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month |
|---|---|---|
| 2013-09-30 | -$0.03 10-Q · filed 2013-12-04 | -$0.05 10-Q · filed 2013-12-04 |